Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108589 · ClinicalTrials.gov registry record · Phase 3
S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00108589: Completed Phase 3 study, sponsored by US Department of Veterans Affairs.
NCT00108589 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108589, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A placebo controlled trial will then examine the effect of S-adenosylmethionine over time on clinical outcome in these patients. It is expected that this agent will slow or halt the progression of this disease.
Interventions
- DRUG S-adenosylmethionine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-01 |
| Est. Completion | 2006-12 |
| Phase | Phase 3 |
What the finished NCT00108589 record still lists
NCT00108589 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which S-adenosylmethionine is the first listed.
NCT00108589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108589 about?
NCT00108589 is a clinical study titled "S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis". The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be accomplished by development of a database of these patients, all of whom will have biopsy documented NASH. A place...
What is the current status of trial NCT00108589?
This trial is currently completed. It is a Phase 3 study. The study started on 2004-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00108589?
The interventions under investigation include: S-adenosylmethionine (DRUG).
Who is sponsoring clinical trial NCT00108589?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia